quipazine has been researched along with corticosterone in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (61.90) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boggan, WO; Buckholtz, NS; Meyer, JS | 1 |
| Clemens, JA; Fuller, RW; Snoddy, HD | 1 |
| Fuller, RW; Snoddy, HD | 4 |
| Ignar, DM; Kuhn, CM; Windh, RT | 1 |
| Alper, RH | 1 |
| Freeman, GB; Thurmond, JB | 1 |
| Bloomquist, WL; Cohen, ML; Fuller, RW; Snoddy, HD | 1 |
| Fuller, RW; Mason, NR | 1 |
| Cohen, ML; Fuller, RW; Kurz, KD; Mason, NR; Meyers, DB; Parli, CJ; Smallwood, JK; Toomey, RE | 1 |
| Cheung, A; Hall, TR; Harvey, S | 1 |
| Cohen, ML; Fuller, RW; Kurz, KD; Mason, NR | 1 |
| Cohen, ML; Fuller, RW; Garbrecht, WL; Kurz, KD; Marzoni, GP; Mason, NR | 1 |
| Clemens, JA; Fuller, RW; Hemrick-Luecke, SK; Mason, NR; Snoddy, HD | 1 |
| Ganong, WF; Van de Kar, LD; Wilkinson, CW | 1 |
| Calligaro, DO; Cohen, ML; Fuller, RW; Kurz, KD | 1 |
| Fuller, RW; Hemrick-Luecke, SK | 1 |
| Evans, DC; Hemrick-Luecke, SK | 1 |
| Benvenga, MJ; Bymaster, FP; Calligaro, DO; Cohen, IR; Falcone, JF; Hemrick-Luecke, SK; Martin, FM; Moore, NA; Nelson, DL; Nisenbaum, LK; Rasmussen, K; Schaus, JM; Sundquist, SJ; Tupper, DE; Wiernicki, TR | 1 |
21 other study(ies) available for quipazine and corticosterone
| Article | Year |
|---|---|
Serotonergic stimulation of pituitary-adrenal activity in the mouse.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Benserazide; Carbidopa; Carbolines; Corticosterone; Cyproheptadine; Female; Fenclonine; Indoles; Metergoline; Mice; Pargyline; Phenyl Ethers; Pituitary-Adrenal System; Propylamines; Quinolines; Quipazine; Spiperone; Tryptophan | 1978 |
The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Atropine; Corticosterone; Dose-Response Relationship, Drug; Fluoxetine; Male; Metergoline; Quinolines; Quipazine; Rats; Serotonin Antagonists | 1978 |
Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidate.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Corticosterone; Dopamine Antagonists; Drug Evaluation, Preclinical; Male; Neurosecretory Systems; Olanzapine; Pergolide; Pirenzepine; Quipazine; Rats; Rats, Inbred Strains; Serotonin Antagonists | 1992 |
Chronic administration of U50,488H fails to produce hypothalamo-pituitary-adrenal axis tolerance in neonatal rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Aging; Analgesics; Animals; Animals, Newborn; Corticosterone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Hypothalamo-Hypophyseal System; Morphine; Physostigmine; Pituitary-Adrenal System; Pyrrolidines; Quipazine; Rats; Rats, Inbred Strains | 1992 |
Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat.
Topics: Amidines; Amphetamines; Animals; Corticosterone; Dexamethasone; Ergolines; Male; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1990 |
Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Corticosterone; Male; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1990 |
Monoamines and effects of chlordiazepoxide on the corticosterone response to stress.
Topics: Animals; Apomorphine; Biogenic Amines; Chlordiazepoxide; Clonidine; Corticosterone; Hydroxyindoleacetic Acid; Male; Mice; Quipazine; Stress, Physiological | 1986 |
Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
Topics: Animals; Blood Pressure; Corticosterone; Ketanserin; Male; Piperidines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin Antagonists | 1989 |
Flumezapine, an antagonist of central dopamine and serotonin receptors.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Benzomorphans; Corticosterone; Dopamine Antagonists; In Vitro Techniques; Male; Pergolide; Quipazine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists | 1986 |
Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Topics: Animals; Brain; Corticosterone; Dose-Response Relationship, Drug; Ergolines; Guinea Pigs; Heart; Lysergic Acid; Male; Membranes; Muscle, Smooth, Vascular; Pergolide; Quipazine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists; Trachea | 1988 |
Serotoninergic regulation of corticosterone secretion in domestic fowl.
Topics: 5,6-Dihydroxytryptamine; Animals; Chickens; Corticosterone; Cyproheptadine; Dexamethasone; Dose-Response Relationship, Drug; Female; Male; Quipazine; Serotonin | 1987 |
Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.
Topics: Amidines; Animals; Blood Pressure; Cerebral Cortex; Corticosterone; Decerebrate State; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Quipazine; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1986 |
Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists.
Topics: Animals; Blood Pressure; Cerebral Cortex; Corticosterone; Decerebrate State; Ergolines; Isomerism; Male; Mathematics; Quipazine; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Serotonin; Spiperone; Time Factors | 1985 |
Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
Topics: Animals; Brain; Brain Chemistry; Corticosterone; Drinking Behavior; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; Piperazines; Prolactin; Quinolines; Quipazine; Rats; Serotonin; Synapses | 1981 |
Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
Topics: Amphetamines; Animals; Corticosterone; Fenclonine; Fenfluramine; Fluoxetine; Male; p-Chloroamphetamine; Quipazine; Rats; Serotonin | 1980 |
Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.
Topics: 5,7-Dihydroxytryptamine; Adrenalectomy; Animals; Brain Chemistry; Corticosterone; Fenclonine; Male; p-Chloroamphetamine; Quipazine; Rats; Rats, Inbred Strains; Renin; Serotonin; Tryptophan | 1981 |
Central serotonin antagonist activity of ketanserin.
Topics: Animals; Brain; Corticosterone; Ketanserin; Male; Piperidines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1984 |
Comparative 5-HT2-receptor antagonist activity of amesergide and its active metabolite 4-hydroxyamesergide in rats and rabbits.
Topics: Adenosine Diphosphate; Animals; Blood Pressure; Corticosterone; Ergolines; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Platelet Aggregation; Quipazine; Rabbits; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cell Surface; Serotonin Antagonists | 1994 |
Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212.
Topics: Animals; Corticosterone; Fluorobenzenes; Indoles; Male; Piperidines; Pyrazines; Quipazine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Urea | 1996 |
Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
Topics: Aminopyridines; Amphetamines; Animals; Corticosterone; Dose-Response Relationship, Drug; Ethylamines; Fluorobenzenes; Hypothalamo-Hypophyseal System; Indoles; Male; Piperazines; Piperidines; Quipazine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2002 |
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Catalepsy; Cocaine; Corticosterone; Drug Evaluation, Preclinical; Electrochemistry; Electrophysiology; Fasting; Female; Immunohistochemistry; Male; Molecular Structure; Motor Activity; Nucleus Accumbens; Olanzapine; Piperazines; Prolactin; Quipazine; Radioligand Assay; Rats; Rats, Inbred F344; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Histamine H1; Serotonin Receptor Agonists; Thiophenes; Time Factors | 2005 |